technology
CRISPR-Cas
Cas-enzyme guided nucleic-acid detection and editing.
Where it's used
Base editing
Base editors (CBE/ABE) make single-nucleotide changes C·G→T·A and A·T→G·C without double-strand breaks — treating monogenic disease (sickle cell, beta-thalassemia) at up to 90% efficiency with no indels.
CRISPR diagnostics
Cas-enzyme nucleic-acid detection — point-of-care molecular diagnostics from sample to lateral-flow readout.
CRISPR screening as a service
Contract functional-genetic CRISPR screening (pooled sgRNA libraries, lentiviral delivery, NGS) — identifies cancer-resistance genes and drug targets in weeks.
Personalized & regenerative medicine
Gene and cell therapy platforms for rare monogenic and oncological diseases: AAV vectors, lentiviral HSC editing, ex vivo CRISPR (Casgevy) and in vivo CRISPR (LNP delivery) now deliver durable one-time treatments approved by FDA and EMA.
Precision Plant Breeding & CRISPR Crop Editing
Precision plant breeding combines CRISPR crop editing, AI-driven genomic selection and speed breeding to deliver trait-stacked varieties in 3–4 years — compressing a decade of conventional development into a single pipeline.